Christian Ehmann
Stock Analyst at Berenberg Bank
(0.68)
# 4,192
Out of 5,074 analysts
194
Total ratings
41.3%
Success rate
-2.7%
Average return
Main Sectors:
Stocks Rated by Christian Ehmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: EVT Evotec SE | Reiterated: Hold | €3.60 | €2.84 | +26.76% | 41 | Oct 16, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Hold | €24.00 | €32.00 | -25.00% | 15 | Sep 3, 2026 | |
| ETR: EUZ Eckert & Ziegler SE | Reiterated: Buy | €23.00 | €13.30 | +72.93% | 1 | Aug 26, 2026 | |
| ETR: FYB Formycon AG | Reiterated: Buy | €40.00 → €30.00 | €18.98 | +58.06% | 15 | Aug 26, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Reiterated: Buy | €24.00 → €27.00 | €24.50 | +10.20% | 8 | Aug 14, 2026 | |
| SWX: KURN Kuros Biosciences AG | Initiated Coverage: Buy | CHF 32.00 | CHF 20.36 | +57.17% | 1 | Jul 7, 2026 | |
| ETR: DMP Dermapharm Holding SE | Reiterated: Hold | €41.00 | €38.70 | n/a | 4 | Aug 26, 2025 | |
| ETR: DRW3 Drägerwerk AG & Co. KGaA | Reiterated: Buy | €85.00 | €98.40 | n/a | 21 | Jul 14, 2025 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €47.00 | €45.31 | n/a | 23 | May 7, 2025 | |
| ETR: M12 M1 Kliniken AG | Reiterated: Buy | €26.00 → €28.00 | €19.38 | n/a | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €43.00 | €39.18 | n/a | 20 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.80 → €5.90 | €2.86 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €5.60 | €2.79 | n/a | 1 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €16.50 → €17.90 | €0.88 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €30.00 → €33.00 | €13.00 | n/a | 10 | Nov 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €41.00 → €56.00 | €0.89 | n/a | 2 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €4.20 → €3.50 | €0.01 | n/a | 3 | May 5, 2022 |
Evotec SE
Oct 16, 2026
Reiterated: Hold
Price Target: €3.60
Current: €2.84
Upside: +26.76%
Gerresheimer AG
Sep 3, 2026
Reiterated: Hold
Price Target: €24.00
Current: €32.00
Upside: -25.00%
Eckert & Ziegler SE
Aug 26, 2026
Reiterated: Buy
Price Target: €23.00
Current: €13.30
Upside: +72.93%
Formycon AG
Aug 26, 2026
Reiterated: Buy
Price Target: €40.00 → €30.00
Current: €18.98
Upside: +58.06%
SCHOTT Pharma AG & Co. KGaA
Aug 14, 2026
Reiterated: Buy
Price Target: €24.00 → €27.00
Current: €24.50
Upside: +10.20%
Kuros Biosciences AG
Jul 7, 2026
Initiated Coverage: Buy
Price Target: CHF 32.00
Current: CHF 20.36
Upside: +57.17%
Dermapharm Holding SE
Aug 26, 2025
Reiterated: Hold
Price Target: €41.00
Current: €38.70
Upside: n/a
Drägerwerk AG & Co. KGaA
Jul 14, 2025
Reiterated: Buy
Price Target: €85.00
Current: €98.40
Upside: n/a
Fresenius SE & Co. KGaA
May 7, 2025
Reiterated: Buy
Price Target: €47.00
Current: €45.31
Upside: n/a
M1 Kliniken AG
May 6, 2025
Reiterated: Buy
Price Target: €26.00 → €28.00
Current: €19.38
Upside: n/a
Feb 25, 2025
Reiterated: Hold
Price Target: €43.00
Current: €39.18
Upside: n/a
Nov 11, 2024
Reiterated: Buy
Price Target: €12.80 → €5.90
Current: €2.86
Upside: n/a
Feb 7, 2024
Reiterated: Hold
Price Target: €5.60
Current: €2.79
Upside: n/a
Dec 14, 2023
Reiterated: Buy
Price Target: €16.50 → €17.90
Current: €0.88
Upside: n/a
Nov 21, 2023
Reiterated: Buy
Price Target: €30.00 → €33.00
Current: €13.00
Upside: n/a
May 30, 2023
Reiterated: Buy
Price Target: €41.00 → €56.00
Current: €0.89
Upside: n/a
May 5, 2022
Reiterated: Buy
Price Target: €4.20 → €3.50
Current: €0.01
Upside: n/a